An independent FDA advisory panel will debate and vote on whether to authorize the Pfizer vaccine for children ages 5 to 11. The nonbinding vote is expected between 4:30 p.m. and 5 p.m. ET today.
Email this article
Then, the matter heads to the CDC's independent advisory panel to deliberate and vote, which is scheduled for Nov. 2 and Nov. 3. Once the CDC panel votes, CDC Director Rochelle Walensky is expected to make the final sign-off.US sees 7th straight week of drop in daily pediatric casesThe past week marked the seventh consecutive week that the United States has seen a drop in pediatric COVID-19 infections since the pandemic peak of nearly 252,000 cases in early September.
Since the onset of the pandemic, nearly 6.3 million children across the nation have tested positive for COVID-19.Colin Sweeney, 12, gets a shot of the Pfizer COVID-19 vaccine as his mother Nicole put her hand on his shoulder, May 14, 2021, in Pasadena, Calif. Less than 45% of adolescents ages 12 to 17 have been fully vaccinated against COVID-19, according to federal data, and more than 48 million children under 12 remain unvaccinated. But that could soon change, should the Food and Drug Administration and the Centers for Disease Control and Prevention green light COVID-19 vaccinations for kids ages 5 to 11 in the coming weeks.
Moderna CEO Stephane Bancel said the new agreement with the African Union, a continental bloc consisting of the 55 member states that make up the countries of Africa, was facilitated in part by the White House. The deal is separate from the company's agreement with the global vaccine-sharing initiative COVAX to supply up to 500 million doses from late this year through 2022, according to the press release.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer CEO says company will produce 4 billion COVID-19 doses in 2022Pfizer CEO Albert Bourla says the company is increasing its output to meet global demand.
Read more »
Moderna Data Shows Covid-19 Vaccine Produced Strong Immune Response in 6- to 11-Year-OldsModerna said it would submit the results from an interim study to health regulators in the U.S., Europe and elsewhere in seeking authorization for 6- to 11-year-olds.
Read more »
New York City Inches Toward Covid-19 Becoming EndemicNew York City’s high rates of vaccination, some prior infection and precautions are keeping the worst outcomes of Covid-19 in check, epidemiologists say. “We’re on our way to an endemic phase.”
Read more »
Moderna says its COVID-19 vaccine is protective, safe in kids 6 to 11Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and safety was comparable to what was previously seen in clinical trials of adolescents and adults.
Read more »
Moderna Says Its Low-Dose COVID-19 Vaccine Works For Kids 6 To 11Children who received the vaccine developed virus-fighting antibodies similar to levels that young adults produce after full-strength shots, Moderna said.
Read more »
COVID-19 live updates: Cases dropping across US, rising in parts of Midwest, NortheastU.S. releases more details about how foreign tourists and other non-citizen, non-immigrant people flying to the U.S. can comply with recently-announced rules requiring them to be fully vaccinated. These rules go into effect on Nov. 8.
Read more »